Response to oxidative stress could be used to study the treatment of lung adenocarcinoma, for example, KEAP1/NRF2 mutation was a major gene subtype of lung adenocarcinoma, which activated endogenous oxidative stress response and underwent significant metabolic recombination to support enhanced antioxidant generation to treat cancer (20). Here, KEAP1 is linked to lung adenocarcinoma.